The U.S. Food and Drug Administration (FDA) is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) – including certain formulations of amphetamine and methylphenidate – to warn about the risk of weight loss and other adverse rea
Similar Posts
Fromm Family Foods Voluntarily Recalls Bonnihill BeefiBowls Food for Dogs Due to Potential Foreign Material Contamination
MEQUON, WIS. (DECEMBER 3, 2025) – FROMM FAMILY FOODS has issued a recall of 300 cases of Bonnihill Farms BeefiBowls Beef Recipe gently cooked frozen dog food due to potential foreign plastic contamination.Chetak LLC Group Recalls Product Because of Possible Health Risk
Are recalling Frozen ‘Deep Sprouted Mat(Moth) 16 oz. and Deep Sprouted Moong 16oz. because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infection in young children, frail or elderly people and others with weakened immune system.Force Forever may be harmful due to hidden drug ingredients
Consumers should not to purchase or use Force Forever, a product promoted and sold for joint painTBC Distribution Corporate Recalls Lucky Foods Brand Cinnamon Powder Because of Possible Health Risk
TBC Distribution Corporate of Brooklyn, NY is recalling Lucky Foods brand Cinnamon Powder 40g, best before date 15.09.2027 because it has the potential to be contaminated with elevated levels of lead. ShortPDUFA VI: Fiscal Years 2018 – 2022
PDUFA VI: Fiscal Years 2018 – 2022Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement – FDA Safety Communication
Read the FDA’s recommendations related to Accolade pacemaker devices by Boston Scientific and a potential need for early device replacement.